Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.

Por Renauld-Mongénie, G, Mielcarek, N, Cornette, J, Schacht, A M, Capron, A, Riveau, G, Locht, C
Publicado em 1996

Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen.

Por Mielcarek, N, Cornette, J, Schacht, A M, Pierce, R J, Locht, C, Capron, A, Riveau, G
Publicado em 1997

Gender-dependent specific immune response during chronic human Schistosomiasis haematobia

Por Remoué, F, To Van, D, Schacht, A-M, Picquet, M, Garraud, O, Vercruysse, J, Ly, A, Capron, A, Riveau, G
Publicado em 2001

Treatment outcomes with ixekizumab in patients with moderate‐to‐severe psoriasis who have or have not received prior biological therapies: an integrated analysis of two Phase III r...

Por Gottlieb, A.B., Lacour, J.‐P., Korman, N., Wilhelm, S., Dutronc, Y., Schacht, A., Erickson, J., Zhang, L., Mallbris, L., Gerdes, S.
Publicado no J Eur Acad Dermatol Venereol (2016)